Latest filing published 16 May 2017 for Navidea Biopharmaceuticals, INC., €44k.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Michael M. Goldberg has filed trades across 5 companies (mainly through SEC (Form 4)), most often in Navidea Biopharmaceuticals, Inc., Emisphere Technologies Inc and Echo Therapeutics, Inc. Over a trading history stretching from 15 October 2006 to 16 May 2017, the count stands at 19 filings.
No open-market sale appears; the market trades are 4 purchases worth €87k. The totals do not cover 2 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 15 share grants.
The record was last updated on 16 May 2017 with a share grant (€44k) in Navidea Biopharmaceuticals, Inc. The most recent open-market purchase was published on 17 November 2014, 4,359 days ago. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
18 of 18 declarations